NCT01099475

Brief Summary

In order to prevent excessive blood loss during liver surgery, an intermittent Pringle manoeuvre (IPM) can be applied. This implies a temporary clamping of the portal vein and hepatic artery in the hepatoduodenal ligament in order to occlude hepatic inflow. The optimal duration of the IPM is unknown. This randomized controlled trial aimed to analyse differences in hepatocellular damage after 15 minutes or 30 minutes IPM during liver surgery for primary or secondary liver tumours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 7, 2010

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

October 17, 2014

Completed
Last Updated

October 17, 2014

Status Verified

October 1, 2014

Enrollment Period

1.8 years

First QC Date

April 1, 2010

Results QC Date

January 18, 2014

Last Update Submit

October 13, 2014

Conditions

Keywords

liver surgerypringle manoeuvrehepatocellular damagesurgical complicationspatients requiring liver surgery

Outcome Measures

Primary Outcomes (1)

  • Hepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels

    At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3. This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Bmj 1990;300:230-5).

    L-FABP area under curve from start of surgery up until postoperative day 3

Secondary Outcomes (3)

  • Post-resectional Complications

    within 90-days after initial liver surgery

  • Amount of Blood Loss

    at the end of liver surgery, an average of 225 minutes

  • Hepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels

    ALAT area under curve from start of surgery up until postoperative day 3

Study Arms (2)

Pringle manoeuvre 15 minutes

EXPERIMENTAL

When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. During inflow occlusion, the complete portal triad was clamped using a rubber sling.

Procedure: Pringle manoeuvre 15 minutes

Pringle manoeuvre 30 minutes

EXPERIMENTAL

When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion. During inflow occlusion, the complete portal triad was clamped using a rubber sling.

Procedure: Pringle manoeuvre 30 minutes

Interventions

During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion

Pringle manoeuvre 15 minutes

During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion

Pringle manoeuvre 30 minutes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients \> 18 years of age and \< 100 years of age
  • primary or secondary liver tumours requiring liver surgery

You may not qualify if:

  • pre-existent liver disease (e.g. inflammatory liver disease, cirrhosis, inborn errors of metabolism)
  • cholangiocarcinoma requiring biliary tract reconstruction during surgery
  • steroid hormone medication
  • tumours deemed irresectable during liver surgery
  • laparoscopic liver surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Centre

Maastricht, PO Box 5800, 6202 AZ, Netherlands

Location

Related Publications (2)

  • van den Broek MA, Bloemen JG, Dello SA, van de Poll MC, Olde Damink SW, Dejong CH. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol. 2011 Aug;55(2):337-45. doi: 10.1016/j.jhep.2010.11.024. Epub 2010 Dec 13.

  • Dello SA, Reisinger KW, van Dam RM, Bemelmans MH, van Kuppevelt TH, van den Broek MA, Olde Damink SW, Poeze M, Buurman WA, Dejong CH. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One. 2012;7(1):e30539. doi: 10.1371/journal.pone.0030539. Epub 2012 Jan 24.

MeSH Terms

Conditions

Hemorrhage

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. MAJ van den Broek, MD
Organization
Maastricht University Medical Centre

Study Officials

  • Cornelis HC Dejong, MD, PhD

    Maastricht University Medical Centre

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2010

First Posted

April 7, 2010

Study Start

October 1, 2007

Primary Completion

July 1, 2009

Study Completion

April 1, 2011

Last Updated

October 17, 2014

Results First Posted

October 17, 2014

Record last verified: 2014-10

Locations